Viewing Study NCT00905593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-01-04 @ 12:48 AM
Study NCT ID: NCT00905593
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2012-07-18
First Post: 2009-05-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic myeloid leukemia, View
None blast crisis, View
None accelerated phase, View
None nilotinib, View
None imatinib, View
None resistant, View
None intolerant, View
None chronic phase View